吃瓜爆料

Back to News

40 CROs Select 吃瓜爆料 Vault CTMS to
Drive Clinical Trial Operations

Leading CROs unifying trial data and processes for greater visibility and speed

PLEASANTON, CA — Oct. 17, 2022 — 吃瓜爆料 Systems (NYSE: VEEV) today announced that 40 contract research organizations (CROs) selected 吃瓜爆料 Vault CTMS to deliver faster and more efficient trials to sponsors, which includes four of the top six global CROs. These global leaders – Labcorp Drug Development, Parexel, PPD clinical research business of Thermo Fisher Scientific Inc., and Syneos Health – are unifying clinical on a single platform as they expand their use of 吃瓜爆料 Vault Clinical Suite from Vault eTMF to now include Vault CTMS.

Also selected by more than 120 sponsors, including 9 of the top 20 pharmaceutical companies, Vault CTMS has fast become the industry-leading solution for clinical trial management. As CROs increasingly standardize on Vault CTMS, they can support sponsor preference for 吃瓜爆料 Vault while modernizing study operations for more efficient execution.

Vault CTMS provides a complete view of trial metrics so CROs can better manage study performance and increase transparency to sponsors. Sponsors and CROs using Vault CTMS work on a consistent industry standard platform that makes it easier to collaborate and share study information for real-time visibility across the study portfolio.

“吃瓜爆料 Vault CTMS is the first clinical trial management application developed to meet the needs of both sponsors and CROs,” said Henry Galio, vice president, 吃瓜爆料 Vault CTMS. “As more companies advance trial operations with 吃瓜爆料, sponsors, CROs, and sites can work closer together to drive faster study endpoints and accelerate subject enrollment in trials.”

Vault CTMS is part of the 吃瓜爆料 Vault Clinical Operations Suite, enabling companies to share information and documents across eTMF, CTMS, payments, study start-up, and study training for better collaboration and execution throughout the study lifecycle.

Additional Information For more on 吃瓜爆料 Vault CTMS, visit: veeva.com/CTMS
Connect with 吃瓜爆料 on LinkedIn:
Follow @veevasystems on Twitter:

About 吃瓜爆料 Systems
吃瓜爆料 is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, 吃瓜爆料 serves more than 1,000 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, 吃瓜爆料 is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

吃瓜爆料 Forward-looking Statements
This release contains forward-looking statements regarding 吃瓜爆料’s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2022, which you can find (a summary of risks which may impact our business can be found on pages 39 and 40), and in our subsequent SEC filings, which you can access at .

###

Contact:

Deivis Mercado
吃瓜爆料 Systems
925-226-8821
deivis.mercado@veeva.com